Kanker prostat inggih punika kanker sané pinih katah kaping kalih ring manusa ring sajebag jagat, antuk kirang langkung 1,276 yuta kasus anyar sané kacarita ring warsa 2018, sané nyihnayang 7,1% saking makasami kasus kanker ring manusa.
Angka kematian antuk kanker prostat taler tegeh, antuk kirang langkung 37.005 padem ring sajebag jagat ring warsa 2018.
Nanging, tingkat kematian punika mabinayan pisan manut ring wewidangan, antuk Afrika Barat madué risiko pinih tegeh kaping lima antuk kematian kanker prostat ring jagaté, miwah Nigeria madué populasi miwah ekonomi pinih ageng ring wewidangan puniki.
Ring Nigeria, kanker prostat inggih punika kanker sané pinih katah miwah sané pinih ngamademang anak lanang, antuk kirang langkung 32,8 kasus miwah 16,3 padem saking 100.000 anak lanang.
Puniki lewih saking tikel ping kalih tingkat kematian ring Amerika Utara.
Panggihin geringé sané kasep, sumber daya sané kawatesin antuk nyelehin miwah nyelehin, miwah panurunan dokumentasi miwah pelaporan kasus sané ngawinang akéhnyané padem ring Nigeria.
Ring Amerika Serikat, kanker prostat inggih punika sané pinih akéh ngawinang padem ring kanker ring anak lanang, antuk kirang langkung 40.000 anak lanang padem saking panyungkané punika nyabran warsa.
Angka kematian kanker prostat sampun alon-alon tedun saking pangawit warsa 1990-an, nanging kantun dados pikobet kesehatan sane signifikan.
Ring makasami, kanker prostat inggih punika panyungkan sane ngamademang, utaminnyane ring wewidangan sane nenten polih perawatan medis miwah sumber daya skrining.
Nakata S, Takahashi H, Ohtake N, Takei T, Yamanaka H: Trends and characteristics in prostate cancer mortality in Japan. Int J Urol. 2000, 7 (7): 254-7.
Pishgar F, Ebrahimi H, Saeedi Moghaddam S, Fitzmaurice C, Amini E: Global, Regional and National Burden of Prostate Cancer, 1990 to 2015: Results from the Global Burden of Disease Study 2015. J Urol. 2018, 199 (5): 1224-1232.
Cai Q, Chen Y, Zhang D, Pan J, Xie Z, Xu C, Li S, Zhang X, Gao Y, Hou J, Guo X, Zhou X, Zhang B, Ma F, Zhang W, Lin G, Xin Z, Niu Y, Wang Y: Estimates of over-time trends in incidence and mortality of prostate cancer from 1990 to 2030. Transl Androl Urol. 2020, 9 (2): 196-209.
Feletto E, Bang A, Cole-Clark D, Chalasani V, Rasiah K, Smith DP: An examination of prostate cancer trends in Australia, England, Canada and USA: Is the Australian death rate too high? World J Urol. 2015, 33 (11): 1677-87.
Taksler GB, Keating NL, Cutler DM: Explaining racial differences in prostate cancer mortality. Cancer. 2012, 118 (17): 4280-9.
['Pambébasan: médis']
['Situs web puniki wantah kaanggén genah malajah miwah informasi, nénten dados genah ngicénin piteket utawi layanan medis.']
['Gatra sane kawedar nenten dados kaanggen anggen nyelehin utawi ngubadin pikobet utawi penyakit kesehatan, lan anake sane ngrereh piteket medis pribadi patut matemu ring dokter sane madue lisensi.']
['Elingang yéning jaringan saraf sané ngasilang pasaur ring pitakén, nénten akurat yéning indiknyané indik angka.']
['Tulung ja nunas piteket saking dokter utawi dokter sane sampun kualifikasi indik kahanan medis. Sampunang ja ngutang piteket saking dokter utawi nunda piteket santukan wenten sane sampun kawacen ring situs puniki. Yening wenten pikobet medis, gelis hubungi 911 utawi ka ruang gawat darurat sane nampek.']
['Sanggahan: hak cipta']
['Digital Millennium Copyright Act saking warsa 1998, 17 U.S.C. § 512 (DMCA) ngicenin hak antuk sang sane maduwe hak cipta sane percaya materi sane wenten ring internet nglanggar hak ipun manut undang-undang hak cipta AS. ']
['Yening semeton pracaya antuk manah sane becik indik daging utawi bahan sane kasayagayang ring situs utawi layanan titiang mamurug hak cipta semeton, semeton (utawi agen) dados ngirimang gatra ring titiang nunas daging utawi bahan punika kaicalang, utawi akses ka blokir.']
['Pangumuman patut katur antuk surat utawi email (cingak bagian "Kontak" antuk alamat email).']
['DMCA ngarsayang mangda gatra indik pelanggaran hak cipta sane kaaduang madaging informasi sane kawedar: (1) deskripsi karya sane kacakup hak cipta sane kaaduang dados subyek pelanggaran; (2) deskripsi konten sane kaaduang nglanggar hak cipta lan informasi sane jangkep anggen iraga ngerereh konten punika; (3) informasi kontak ragane, rumasuk alamat, nomor telepon, miwah alamat email; (4) pernyataan ragane sane madasar antuk kapracayan sane becik indik konten sane kaaduang nenten kaicen wewenang olih sang sane maduwe hak cipta, utawi agennyane, utawi antuk hukum napi manten; ']
['(5) pernyataan saking ragane, sane katanda tanganin antuk hukuman sumpah palsu, indik informasi ring notifikasi punika akurat lan ragane madue wewenang antuk ngukuhang hak cipta sane kaucap sampun dilanggar; ']
['miwah (6) tanda tangan fisik utawi elektronik saking sang sane maduwe hak cipta utawi anak sane madue kuasa ngamargiang pakaryan saking sang sane maduwe hak cipta. ']
['Yening nenten ngranjingang makasami informasi ring ajeng prasida ngawinang penanganan keluhan sayan sué.']
['Kontak sareng']
['Tulung kirim email antuk pitaken/usulan.']
How deadly is prostate cancer?
Prostate cancer is the second most common cancer in men worldwide, with an estimated 1.276 million new cases reported in 2018, representing 7.1% of all cancer cases in men.
The mortality rate for prostate cancer is also high, with an estimated 37,005 deaths worldwide in 2018.
However, the mortality rate varies greatly by region, with Western Africa having the fifth-highest risk for prostate cancer mortality in the world, and Nigeria having the largest population and economy in this region.
In Nigeria, prostate cancer is both the most common and most deadly cancer for men, with an estimated 32.8 cases and 16.3 deaths per 100,000 men.
This is more than double the death rate in North America.
Late detection of the disease, limited resources for screening and detection, and decreased documentation and reporting of cases contribute to the high mortality rate in Nigeria.
In the United States, prostate cancer is the second most common cause of cancer death in men, with approximately 40,0000 men dying from the disease each year.
The prostate cancer death rate has been slowly decreasing since the early 1990s, but it remains a significant health concern.
Overall, prostate cancer is a deadly disease, particularly in regions with limited access to medical care and screening resources.
However, early detection and treatment can significantly improve outcomes and reduce mortality rates.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
